Published in Gastroenterol Clin North Am on December 01, 2007
Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med (2009) 10.01
Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res (2011) 4.84
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut (2010) 4.01
Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling. PLoS One (2009) 1.90
Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res (2013) 1.42
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer (2008) 1.30
Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev (2008) 1.18
Reinterpretation of histology of proximal colon polyps called hyperplastic in 2001. World J Gastroenterol (2009) 1.11
Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer. Oncotarget (2012) 1.08
Dvl2 promotes intestinal length and neoplasia in the ApcMin mouse model for colorectal cancer. Cancer Res (2010) 1.07
Sessile serrated adenomas: demographic, endoscopic and pathological characteristics. World J Gastroenterol (2010) 1.03
Heterogeneity of colorectal adenomas, the serrated adenoma, and implications for screening and surveillance. World J Gastroenterol (2008) 1.01
No evidence for human papillomavirus in the etiology of colorectal polyps. Cancer Epidemiol Biomarkers Prev (2011) 1.01
Prevalence of different subtypes of serrated polyps and risk of synchronous advanced colorectal neoplasia in average-risk population undergoing first-time colonoscopy. Clin Transl Gastroenterol (2012) 1.00
Polyp size measurement at CT colonography: what do we know and what do we need to know? Radiology (2010) 1.00
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma. Histopathology (2011) 1.00
Serrated pathway: alternative route to colorectal cancer. World J Gastroenterol (2013) 0.99
CT colonography for population screening: ready for prime time? Dig Dis Sci (2014) 0.97
Association between visceral adiposity and colorectal polyps on CT colonography. AJR Am J Roentgenol (2012) 0.97
Significance of serrated polyps of the colon. Curr Gastroenterol Rep (2008) 0.96
Risk factors for serrated polyps of the colorectum. Dig Dis Sci (2014) 0.96
RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PLoS One (2014) 0.94
Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer (2010) 0.94
Preinvasive colorectal lesion transcriptomes correlate with endoscopic morphology (polypoid vs. nonpolypoid). EMBO Mol Med (2011) 0.93
BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications. Oncotarget (2014) 0.92
Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? BMC Cancer (2010) 0.91
Contrast coating for the surface of flat polyps at CT colonography: a marker for detection. Eur Radiol (2014) 0.89
Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps. Nutr Cancer (2011) 0.89
Management of serrated adenomas and hyperplastic polyps. Clin Colon Rectal Surg (2008) 0.86
Annex to Quirke et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: annotations of colorectal lesions. Virchows Arch (2011) 0.86
Nanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesions. Proteomics (2013) 0.84
Serrated polyps of right colon: guilty or innocent? Ann Gastroenterol (2013) 0.84
Automated measurement of colorectal polyp height at CT colonography: hyperplastic polyps are flatter than adenomatous polyps. AJR Am J Roentgenol (2009) 0.83
State of the Art Review: Colorectal Cancer Screening. Am J Lifestyle Med (2011) 0.81
Molecular pathogenesis of sporadic colorectal cancers. Chin J Cancer (2016) 0.81
Regulation of homeostasis and oncogenesis in the intestinal epithelium by Ras. Exp Cell Res (2011) 0.80
Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial. Clin Gastroenterol Hepatol (2008) 0.78
Serrated polyps of the colon. F1000 Med Rep (2010) 0.77
Histopathologic study of the rectum in 1,438 consecutive rectal specimens in a single Japanese hospital: I. benign lesions. Int J Clin Exp Pathol (2013) 0.77
Computer disease simulation models: integrating evidence for health policy. Acad Radiol (2011) 0.77
Associations among pericolonic fat, visceral fat, and colorectal polyps on CT colonography. Obesity (Silver Spring) (2014) 0.76
The frequency of early colorectal cancer derived from sessile serrated adenoma/polyps among 1858 serrated polyps from a single institution. Int J Colorectal Dis (2015) 0.76
Gastric Proteins MUC5AC and TFF1 as Potential Diagnostic Markers of Colonic Sessile Serrated Adenomas/Polyps. Am J Clin Pathol (2016) 0.75
Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype. Cancer Prev Res (Phila) (2016) 0.75
Serrated colorectal polyps in inflammatory bowel disease. Mod Pathol (2015) 0.75
The clinical impact of serrated colorectal polyps. Clin Epidemiol (2017) 0.75
The Serrated Polyp Pathway: Is It Time to Alter Surveillance Guidelines? Curr Gastroenterol Rep (2017) 0.75
Pathological features of the sessile serrated adenoma/polyp with special references of its carcinogenesis. Med Mol Morphol (2014) 0.75
[In situ analyses of molecular mechanisms of colorectal carcinogenesis]. Pathologe (2013) 0.75